Evidence map›Paper›PMID 34737274›Full record

ArticleNature communications2021

MOFs-based nanoagent enables dual mitochondrial damage in synergistic antitumor therapy via oxidative stress and calcium overload.

Weier Bao, Ming Liu, Jiaqi Meng, Siyuan Liu, Shuang Wang, Rongrong Jia, Yugang Wang, Guanghui Ma, Wei Wei, Zhiyuan Tian

Abstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Mechanism of glycolysis-pyrolysis crosstalk driving vicious circle of intervertebral disc degeneration.Apoptosis : an international journal on programmed cell death · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Concave-Octahedral FeGels (Basel, Switzerland) · 2025
    Article
  14. Review
  15. Dysregulation of Mitochondrial Function in Cancer Cells.International journal of molecular sciences · 2025
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Weier BaoSchool of Chemical Sciences, University of Chinese Academy of Sciences, 100049, Beijing, P. R. China.
Ming LiuSchool of Chemical Sciences, University of Chinese Academy of Sciences, 100049, Beijing, P. R. China.
Jiaqi MengSchool of Chemical Sciences, University of Chinese Academy of Sciences, 100049, Beijing, P. R. China.
Siyuan LiuSchool of Chemical Sciences, University of Chinese Academy of Sciences, 100049, Beijing, P. R. China.
Shuang WangState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, 100190, Beijing, P. R. China.ORCID 0000-0002-9189-602X
Rongrong JiaDepartment of Gastroenterology, Shanghai Tongren Hospital, Shanghai Jiao Tong University School of Medicine, 200336, Shanghai, P. R. China.
Yugang WangDepartment of Gastroenterology, Shanghai Tongren Hospital, Shanghai Jiao Tong University School of Medicine, 200336, Shanghai, P. R. China.ORCID 0000-0001-5675-2509
Guanghui MaState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, 100190, Beijing, P. R. China. ghma@ipe.ac.cn.ORCID 0000-0001-9154-5556
Wei WeiState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, 100190, Beijing, P. R. China. weiwei@ipe.ac.cn.ORCID 0000-0002-6244-3187
Zhiyuan TianSchool of Chemical Sciences, University of Chinese Academy of Sciences, 100049, Beijing, P. R. China. zytian@ucas.ac.cn.ORCID 0000-0002-1436-6818

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Targeting subcellular organelle with multilevel damage has shown great promise for antitumor therapy. Here, we report a core-shell type of nanoagent with iron (III) carboxylate metal-organic frameworks (MOFs) as shell while upconversion nanoparticles (UCNPs) as core, which enables near-infrared (NIR) light-triggered synergistically reinforced oxidative stress and calcium overload to mitochondria. The folate decoration on MOFs shells enables efficient cellular uptake of nanoagents. Based on the upconversion ability of UCNPs, NIR light mediates Fe

Indexed as

CalciumHeLa CellsHumansHydroxyl RadicalInfrared RaysMetal-Organic FrameworksMitochondriaNanostructuresOxidative StressCalciumHydroxyl RadicalMetal-Organic Frameworks

Identifiers

PMID34737274
PMCPMC8569165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.